Connection

Lukas Weseslindtner to Antibodies, Viral

Back to Details
This is a "connection" page, showing publications Lukas Weseslindtner has written about Antibodies, Viral.
Lukas Weseslindtner
Connection Strength
0.329
Antibodies, Viral
  1. Assessment of S1-, S2-, and NCP-Specific IgM, IgA, and IgG Antibody Kinetics in Acute SARS-CoV-2 Infection by a Microarray and Twelve Other Immunoassays. J Clin Microbiol. 2021 04 20; 59(5).
    View in: PubMed
    Score: 0.089
  2. Diagnosis of COVID-19 using multiple antibody assays in two cases with negative PCR results from nasopharyngeal swabs. Infection. 2021 Feb; 49(1):171-175.
    View in: PubMed
    Score: 0.085
  3. Performance of Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Assays in Different Stages of Infection: Comparison of Commercial Enzyme-Linked Immunosorbent Assays and Rapid Tests. J Infect Dis. 2020 07 06; 222(3):362-366.
    View in: PubMed
    Score: 0.084
  4. Humoral response to COVID-19 infection in immunosuppressed patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2021 03 01; 33(3):443-447.
    View in: PubMed
    Score: 0.022
  5. Antibody kinetics in primary- and secondary-care physicians with mild to moderate SARS-CoV-2 infection. Emerg Microbes Infect. 2020 Dec; 9(1):1692-1694.
    View in: PubMed
    Score: 0.022
  6. Quantification of SARS-CoV-2 antibodies with eight commercially available immunoassays. J Clin Virol. 2020 08; 129:104540.
    View in: PubMed
    Score: 0.021
  7. Lessons from low seroprevalence of SARS-CoV-2 antibodies in schoolchildren: A cross-sectional study. Pediatr Allergy Immunol. 2021 05; 32(4):762-770.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.